
|Articles|November 1, 2002
Stockholders to vote: Investments breathe life into ISTA Pharmaceuticals
Irvine, CA-ISTA Pharmaceuticals Inc. has secured $44 million in financing, including a $4 million bridge loan, to complete development work on late-stage ophthalmic products in the company's clinical pipeline.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: Retinal signs as diagnostic clues to systemic metabolic disease
2
EURETINA 2026: Predicting geographic atrophy progression with DARC
3
EURETINA 2026: Gene therapy sessions to watch in Vienna
4
MOGENRY earns Japan priority review for inherited retinal dystrophies
5
















